Skip to main content

Table 1 Clinical characteristics of 41 RA patients at follow-up visit (T6)

From: Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis

Variables

Results

Demographic variables:

 Age, years

53.3 (8.7) (28–68)

 Gender, F/M

34 (82.9)/ 7 (17)

Cardiovascular risk factors:

 Family history of CVD

20 (48.8)

 Current/Ex-smokers

23 (56.1)

 Hypertension

17 (41.5)

 Diabetes

3 (7.3)

 CKD3a (eGFR 45–59 ml/min/1.73 m2)

2 (4.9)

 AI abnormal

11 (26.8)

 BMI > 30 kg/m2

5 (12.2)

 Physical inactivity

23 (56.1)

RA related variables

 Disease duration, years

19.2 (9.2) (8–45)

 Erosions (X-ray of hands/feet)

35 (85.4)

 Extra-articular symptoms

28 (68.3)

 Positive RF-IgM

33 (80.5)

 Positive anti-CCP2

30 (73.2)

 ESR, mm/h

19.2 (16.0) (2–64)

 CRP, mg/l

14.35 (37.5) (0.1–228.5)

 Average CRP (6 years), mg/l

11.02 (9.9) (0.9–37.3)

 Low RA activity (DAS28 ≤ 3.2)

23 (56.1)

 Current glucocorticoid use

18 (43.9)

 Current conventional synthetic DMARD

39 (95.1)

 Current biological DMARD

32 (78.1)

  1. Data are presented as mean (SD) (range) or number (%); AI atherogenic index, Anti-CCP2 anti-cyclic citrullinated peptide antibodies, BMI body mass index, CVD cardiovascular disease, CKD chronic kidney disease, CRP C-reactive protein; DAS28 disease activity score in 28 joints, DMARD disease modifying antirheumatic drug, eGFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, RF-IgM IgM rheumatoid factor